{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:10:26Z","timestamp":1762431026947},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,6,27]],"date-time":"2015-06-27T00:00:00Z","timestamp":1435363200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12886-015-0044-9","type":"journal-article","created":{"date-parts":[[2015,6,26]],"date-time":"2015-06-26T10:01:12Z","timestamp":1435312872000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Protective effect of 14-3-3 antibodies on stressed neuroretinal cells via the mitochondrial apoptosis pathway"],"prefix":"10.1186","volume":"15","author":[{"given":"Katharina","family":"Bell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corina","family":"Wilding","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Funke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norbert","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franz H.","family":"Grus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,6,27]]},"reference":[{"issue":"1","key":"44_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1172\/JCI200317522","volume":"111","author":"S Przedborski","year":"2003","unstructured":"Przedborski S, Vila M, Jackson-Lewis V. Neurodegeneration: what is it and where are we? J Clin Invest. 2003;111(1):3\u201310.","journal-title":"J Clin Invest"},{"issue":"1","key":"44_CR2","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/S1350-9462(98)00014-7","volume":"18","author":"HA Quigley","year":"1999","unstructured":"Quigley HA. Neuronal death in glaucoma. Prog Retin Eye Res. 1999;18(1):39\u201357.","journal-title":"Prog Retin Eye Res"},{"issue":"6","key":"44_CR3","first-page":"1370","volume":"41","author":"AJ Weber","year":"2000","unstructured":"Weber AJ, Chen H, Hubbard WC, Kaufman PL. Experimental glaucoma and cell size, density, and number in the primate lateral geniculate nucleus. Invest Ophthalmol Vis Sci. 2000;41(6):1370\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9774","key":"44_CR4","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1016\/S0140-6736(10)61423-7","volume":"377","author":"HA Quigley","year":"2011","unstructured":"Quigley HA. Glaucoma. Lancet. 2011;377(9774):1367\u201377.","journal-title":"Lancet"},{"issue":"2","key":"44_CR5","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1097\/ICU.0b013e3280895aea","volume":"18","author":"N Gupta","year":"2007","unstructured":"Gupta N, Yucel YH. Glaucoma as a neurodegenerative disease. Curr Opin Ophthalmol. 2007;18(2):110\u20134.","journal-title":"Curr Opin Ophthalmol"},{"issue":"15","key":"44_CR6","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1056\/NEJM199304153281507","volume":"328","author":"HA Quigley","year":"1993","unstructured":"Quigley HA. Medical progress - open-angle glaucoma. N Engl J Med. 1993;328(15):1097\u2013106.","journal-title":"N Engl J Med"},{"issue":"3","key":"44_CR7","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/bjo.2005.081224","volume":"90","author":"HA Quigley","year":"2006","unstructured":"Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90(3):262\u20137.","journal-title":"Br J Ophthalmol"},{"key":"44_CR8","doi-asserted-by":"publisher","first-page":"38","DOI":"10.2174\/1874364100903020038","volume":"3","author":"AL Coleman","year":"2009","unstructured":"Coleman AL, Kodjebacheva G. Risk factors for glaucoma needing more attention. Open Ophthalmol J. 2009;3:38\u201342.","journal-title":"Open Ophthalmol J"},{"key":"44_CR9","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.2147\/OPTH.S24058","volume":"5","author":"T Mizoguchi","year":"2011","unstructured":"Mizoguchi T, Ozaki M, Wakiyama H, Ogino N. Additive intraocular pressure-lowering effect of dorzolamide 1\u00a0%\/timolol 0.5\u00a0% fixed combination on prostaglandin monotherapy in patients with normal tension glaucoma. Clin Ophthalmol. 2011;5:1515\u201320.","journal-title":"Clin Ophthalmol"},{"issue":"2","key":"44_CR10","doi-asserted-by":"publisher","first-page":"278","DOI":"10.3129\/can j ophthalmol.i07-036","volume":"42","author":"RW Nickells","year":"2007","unstructured":"Nickells RW. From ocular hypertension to ganglion cell death: a theoretical sequence of events leading to glaucoma. Can J Ophthalmol. 2007;42(2):278\u201387.","journal-title":"Can J Ophthalmol"},{"issue":"1","key":"44_CR11","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S0014-4835(95)80056-5","volume":"61","author":"E Garcia-Valenzuela","year":"1995","unstructured":"Garcia-Valenzuela E, Shareef S, Walsh J, Sharma SC. Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp Eye Res. 1995;61(1):33\u201344.","journal-title":"Exp Eye Res"},{"issue":"1","key":"44_CR12","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/S0002-9394(03)00788-8","volume":"137","author":"SM Ferreira","year":"2004","unstructured":"Ferreira SM, Lerner SF, Brunzini R, Evelson PA, Llesuy SF. Oxidative stress markers in aqueous humor of glaucoma patients. Am J Ophthalmol. 2004;137(1):62\u20139.","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"44_CR13","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1016\/S0002-9343(03)00114-1","volume":"114","author":"A Izzotti","year":"2003","unstructured":"Izzotti A, Sacca SC, Cartiglia C, De Flora S. Oxidative deoxyribonucleic acid damage in the eyes of glaucoma patients. Am J Med. 2003;114(8):638\u201346.","journal-title":"Am J Med"},{"issue":"5","key":"44_CR14","first-page":"270","volume":"4","author":"EB Dreyer","year":"1997","unstructured":"Dreyer EB, Grosskreutz CL. Excitatory mechanisms in retinal ganglion cell death in primary open angle glaucoma (POAG). Clin Neurosci. 1997;4(5):270\u20133.","journal-title":"Clin Neurosci"},{"issue":"3","key":"44_CR15","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1001\/archopht.1996.01100130295012","volume":"114","author":"EB Dreyer","year":"1996","unstructured":"Dreyer EB, Zurakowski D, Schumer RA, Podos SM, Lipton SA. Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol. 1996;114(3):299\u2013305.","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"44_CR16","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/S0002-9394(99)80084-1","volume":"125","author":"MB Wax","year":"1998","unstructured":"Wax MB, Tezel G, Saito I, Gupta RS, Harley JB, Li Z, et al. Anti-Ro\/SS-A positivity and heat shock protein antibodies in patients with normal-pressure glaucoma. Am J Ophthalmol. 1998;125(2):145\u201357.","journal-title":"Am J Ophthalmol"},{"issue":"1","key":"44_CR17","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/S0021-5155(01)00455-5","volume":"46","author":"Y Ikeda","year":"2002","unstructured":"Ikeda Y, Maruyama I, Nakazawa M, Ohguro H. Clinical significance of serum antibody against neuron-specific enolase in glaucoma patients. Jpn J Ophthalmol. 2002;46(1):13\u20137.","journal-title":"Jpn J Ophthalmol"},{"issue":"3","key":"44_CR18","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1080\/02713680701871157","volume":"33","author":"J Reichelt","year":"2008","unstructured":"Reichelt J, Joachim SC, Pfeiffer N, Grus FH. Analysis of autoantibodies against human retinal antigens in sera of patients with glaucoma and ocular hypertension. Curr Eye Res. 2008;33(3):253\u201361.","journal-title":"Curr Eye Res"},{"issue":"7","key":"44_CR19","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1001\/archopht.117.7.917","volume":"117","author":"G Tezel","year":"1999","unstructured":"Tezel G, Edward DP, Wax MB. Serum autoantibodies to optic nerve head glycosaminoglycans in patients with glaucoma. Arch Ophthalmol. 1999;117(7):917\u201324.","journal-title":"Arch Ophthalmol"},{"key":"44_CR20","first-page":"132","volume":"10","author":"FH Grus","year":"2004","unstructured":"Grus FH, Joachim SC, Hoffmann EM, Pfeiffer N. Complex autoantibody repertoires in patients with glaucoma. Mol Vis. 2004;10:132\u20137.","journal-title":"Mol Vis"},{"issue":"1\u20132","key":"44_CR21","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0022-1759(98)00074-X","volume":"216","author":"S Lacroix-Desmazes","year":"1998","unstructured":"Lacroix-Desmazes S, Kaveri SV, Mouthon L, Ayouba A, Malanchere E, Coutinho A, et al. Self-reactive antibodies (natural autoantibodies) in healthy individuals. J Immunol Methods. 1998;216(1\u20132):117\u201337.","journal-title":"J Immunol Methods"},{"issue":"5","key":"44_CR22","first-page":"154","volume":"12","author":"S Avrameas","year":"1991","unstructured":"Avrameas S. Natural autoantibodies: from \u2018horror autotoxicus\u2019 to \u2018gnothi seauton\u2019. Immunol Today. 1991;12(5):154\u20139.","journal-title":"Immunol Today"},{"issue":"5","key":"44_CR23","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/S1568-9972(03)00033-8","volume":"2","author":"A Poletaev","year":"2003","unstructured":"Poletaev A, Osipenko L. General network of natural autoantibodies as immunological homunculus (Immunculus). Autoimmun Rev. 2003;2(5):264\u201371.","journal-title":"Autoimmun Rev"},{"key":"44_CR24","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1159\/000212371","volume":"26","author":"MN Meriggioli","year":"2009","unstructured":"Meriggioli MN. Myasthenia gravis with anti-acetylcholine receptor antibodies. Front Neurol Neurosci. 2009;26:94\u2013108.","journal-title":"Front Neurol Neurosci"},{"issue":"7","key":"44_CR25","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.biopsych.2004.12.008","volume":"57","author":"S Brettschneider","year":"2005","unstructured":"Brettschneider S, Morgenthaler NG, Teipel SJ, Fischer-Schulz C, Burger K, Dodel R, et al. Decreased serum amyloid beta (1\u201342) autoantibody levels in Alzheimer\u2019s disease, determined by a newly developed immuno-precipitation assay with radiolabeled amyloid beta (1\u201342) peptide. Biol Psychiatry. 2005;57(7):813\u20136.","journal-title":"Biol Psychiatry"},{"issue":"10","key":"44_CR26","doi-asserted-by":"publisher","first-page":"e46910","DOI":"10.1371\/journal.pone.0046910","volume":"7","author":"K Bell","year":"2012","unstructured":"Bell K, Funke S, Pfeiffer N, Grus FH. Serum and antibodies of glaucoma patients lead to changes in the proteome, especially cell regulatory proteins, in retinal cells. PLoS One. 2012;7(10):e46910.","journal-title":"PLoS One"},{"key":"44_CR27","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/978-1-4614-3209-8_19","volume":"801","author":"C Sippl","year":"2014","unstructured":"Sippl C, Tamm ER. What is the nature of the RGC-5 cell line? Adv Exp Med Biol. 2014;801:145\u201354.","journal-title":"Adv Exp Med Biol"},{"issue":"1","key":"44_CR28","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","volume":"193","author":"OH Lowry","year":"1951","unstructured":"Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193(1):265\u201375.","journal-title":"J Biol Chem"},{"issue":"11","key":"44_CR29","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1016\/j.jprot.2012.03.018","volume":"75","author":"S Funke","year":"2012","unstructured":"Funke S, Azimi D, Wolters D, Grus FH, Pfeiffer N. Longitudinal analysis of taurine induced effects on the tear proteome of contact lens wearers and dry eye patients using a RP-RP-Capillary-HPLC-MALDI TOF\/TOF MS approach. J Proteomics. 2012;75(11):3177\u201390.","journal-title":"J Proteomics"},{"issue":"6","key":"44_CR30","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1167\/iovs.07-1344","volume":"49","author":"X Yang","year":"2008","unstructured":"Yang X, Luo C, Cai J, Pierce WM, Tezel G. Phosphorylation-dependent interaction with 14-3-3 in the regulation of bad trafficking in retinal ganglion cells. Invest Ophthalmol Vis Sci. 2008;49(6):2483\u201394.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"44_CR31","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1016\/j.semcdb.2011.08.005","volume":"22","author":"P Steinacker","year":"2011","unstructured":"Steinacker P, Aitken A, Otto M. 14-3-3 proteins in neurodegeneration. Semin Cell Dev Biol. 2011;22(7):696\u2013704.","journal-title":"Semin Cell Dev Biol"},{"issue":"3","key":"44_CR32","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/emboj\/19.3.349","volume":"19","author":"H Xing","year":"2000","unstructured":"Xing H, Zhang S, Weinheimer C, Kovacs A, Muslin AJ. 14-3-3 proteins block apoptosis and differentially regulate MAPK cascades. EMBO J. 2000;19(3):349\u201358.","journal-title":"EMBO J"},{"issue":"6","key":"44_CR33","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.biocel.2008.10.029","volume":"41","author":"L Chen","year":"2009","unstructured":"Chen L, Liu L, Yin J, Luo Y, Huang S. Hydrogen peroxide-induced neuronal apoptosis is associated with inhibition of protein phosphatase 2A and 5, leading to activation of MAPK pathway. Int J Biochem Cell Biol. 2009;41(6):1284\u201395.","journal-title":"Int J Biochem Cell Biol"},{"key":"44_CR34","first-page":"396","volume":"4","author":"EK Kim","year":"1802","unstructured":"Kim EK, Choi EJ. Pathological roles of MAPK signaling pathways in human diseases. Biochim Biophys Acta. 1802;4:396\u2013405.","journal-title":"Biochim Biophys Acta"},{"issue":"11","key":"44_CR35","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1016\/j.cellsig.2009.07.001","volume":"21","author":"AS Dhillon","year":"2009","unstructured":"Dhillon AS, Yip YY, Grindlay GJ, Pakay JL, Dangers M, Hillmann M, et al. The C-terminus of Raf-1 acts as a 14-3-3-dependent activation switch. Cell Signal. 2009;21(11):1645\u201351.","journal-title":"Cell Signal"},{"issue":"2","key":"44_CR36","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1152\/physrev.2001.81.2.807","volume":"81","author":"JM Kyriakis","year":"2001","unstructured":"Kyriakis JM, Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev. 2001;81(2):807\u201369.","journal-title":"Physiol Rev"},{"issue":"11","key":"44_CR37","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1021\/pr900474t","volume":"8","author":"YM Gozal","year":"2009","unstructured":"Gozal YM, Duong DM, Gearing M, Cheng D, Hanfelt JJ, Funderburk C, et al. Proteomics analysis reveals novel components in the detergent-insoluble subproteome in Alzheimer\u2019s disease. J Proteome Res. 2009;8(11):5069\u201379.","journal-title":"J Proteome Res"},{"key":"44_CR38","doi-asserted-by":"publisher","first-page":"564534","DOI":"10.1155\/2013\/564534","volume":"2013","author":"T Shimada","year":"2013","unstructured":"Shimada T, Fournier AE, Yamagata K. Neuroprotective function of 14-3-3 proteins in neurodegeneration. Biomed Res Int. 2013;2013:564534.","journal-title":"Biomed Res Int"},{"issue":"1","key":"44_CR39","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1385\/MB:27:1:33","volume":"27","author":"AP Yamniuk","year":"2004","unstructured":"Yamniuk AP, Vogel HJ. Calmodulin\u2019s flexibility allows for promiscuity in its interactions with target proteins and peptides. Mol Biotechnol. 2004;27(1):33\u201357.","journal-title":"Mol Biotechnol"},{"issue":"8","key":"44_CR40","doi-asserted-by":"publisher","first-page":"3854","DOI":"10.1167\/iovs.06-1382","volume":"48","author":"W Fan","year":"2007","unstructured":"Fan W, Li X, Cooper NG. CaMKIIalphaB mediates a survival response in retinal ganglion cells subjected to a glutamate stimulus. Invest Ophthalmol Vis Sci. 2007;48(8):3854\u201363.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"44_CR41","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/j.mcn.2011.02.003","volume":"46","author":"NM Ashpole","year":"2011","unstructured":"Ashpole NM, Hudmon A. Excitotoxic neuroprotection and vulnerability with CaMKII inhibition. Mol Cell Neurosci. 2011;46(4):720\u201330.","journal-title":"Mol Cell Neurosci"},{"issue":"28","key":"44_CR42","doi-asserted-by":"publisher","first-page":"25187","DOI":"10.1074\/jbc.M110.192708","volume":"286","author":"JZ Yan","year":"2011","unstructured":"Yan JZ, Xu Z, Ren SQ, Hu B, Yao W, Wang SH, et al. Protein kinase C promotes N-methyl-D-aspartate (NMDA) receptor trafficking by indirectly triggering calcium\/calmodulin-dependent protein kinase II (CaMKII) autophosphorylation. J Biol Chem. 2011;286(28):25187\u2013200.","journal-title":"J Biol Chem"},{"issue":"8","key":"44_CR43","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s00417-004-1094-5","volume":"243","author":"SC Joachim","year":"2005","unstructured":"Joachim SC, Pfeiffer N, Grus FH. Autoantibodies in patients with glaucoma: a comparison of IgG serum antibodies against retinal, optic nerve, and optic nerve head antigens. Graefes Arch Clin Exp Ophthalmol. 2005;243(8):817\u201323.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"4","key":"44_CR44","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00417-007-0737-8","volume":"246","author":"SC Joachim","year":"2008","unstructured":"Joachim SC, Reichelt J, Berneiser S, Pfeiffer N, Grus FH. Sera of glaucoma patients show autoantibodies against myelin basic protein and complex autoantibody profiles against human optic nerve antigens. Graefes Arch Clin Exp Ophthalmol. 2008;246(4):573\u201380.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"29","key":"44_CR45","doi-asserted-by":"publisher","first-page":"12145","DOI":"10.1073\/pnas.0904866106","volume":"106","author":"M Britschgi","year":"2009","unstructured":"Britschgi M, Olin CE, Johns HT, Takeda-Uchimura Y, LeMieux MC, Rufibach K, et al. Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer\u2019s disease. Proc Natl Acad Sci U S A. 2009;106(29):12145\u201350.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"44_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mito.2008.10.003","volume":"9","author":"R Kumarswamy","year":"2009","unstructured":"Kumarswamy R, Chandna S. Putative partners in Bax mediated cytochrome-c release: ANT, CypD, VDAC or none of them? Mitochondrion. 2009;9(1):1\u20138.","journal-title":"Mitochondrion"},{"issue":"Suppl 1","key":"44_CR47","doi-asserted-by":"publisher","first-page":"S151","DOI":"10.1016\/S0039-6257(99)00029-6","volume":"43","author":"RW Nickells","year":"1999","unstructured":"Nickells RW. Apoptosis of retinal ganglion cells in glaucoma: an update of the molecular pathways involved in cell death. Surv Ophthalmol. 1999;43 Suppl 1:S151\u201361.","journal-title":"Surv Ophthalmol"},{"issue":"1","key":"44_CR48","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1371\/journal.pgen.0010004","volume":"1","author":"RT Libby","year":"2005","unstructured":"Libby RT, Li Y, Savinova OV, Barter J, Smith RS, Nickells RW, et al. Susceptibility to neurodegeneration in a glaucoma is modified by Bax gene dosage. PLoS Genet. 2005;1(1):17\u201326.","journal-title":"PLoS Genet"},{"issue":"2","key":"44_CR49","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.visres.2004.08.008","volume":"45","author":"J Ji","year":"2005","unstructured":"Ji J, Chang P, Pennesi ME, Yang Z, Zhang J, Li D, et al. Effects of elevated intraocular pressure on mouse retinal ganglion cells. Vision Res. 2005;45(2):169\u201379.","journal-title":"Vision Res"},{"issue":"8","key":"44_CR50","doi-asserted-by":"publisher","first-page":"2809","DOI":"10.1096\/fj.08-107417","volume":"22","author":"S Yuan","year":"2008","unstructured":"Yuan S, Fu Y, Wang X, Shi H, Huang Y, Song X, et al. Voltage-dependent anion channel 1 is involved in endostatin-induced endothelial cell apoptosis. FASEB J. 2008;22(8):2809\u201320.","journal-title":"FASEB J"},{"issue":"20","key":"44_CR51","doi-asserted-by":"publisher","first-page":"7096","DOI":"10.1128\/MCB.23.20.7096-7107.2003","volume":"23","author":"HY Yang","year":"2003","unstructured":"Yang HY, Wen YY, Chen CH, Lozano G, Lee MH. 14-3-3 sigma positively regulates p53 and suppresses tumor growth. Mol Cell Biol. 2003;23(20):7096\u2013107.","journal-title":"Mol Cell Biol"},{"issue":"25","key":"44_CR52","doi-asserted-by":"publisher","first-page":"22699","DOI":"10.1074\/jbc.M010231200","volume":"276","author":"M Grigorian","year":"2001","unstructured":"Grigorian M, Andresen S, Tulchinsky E, Kriajevska M, Carlberg C, Kruse C, et al. Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1\/S100A4 protein: functional consequences of their interaction. J Biol Chem. 2001;276(25):22699\u2013708.","journal-title":"J Biol Chem"},{"issue":"5","key":"44_CR53","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1083\/jcb.139.5.1281","volume":"139","author":"KG Wolter","year":"1997","unstructured":"Wolter KG, Hsu YT, Smith CL, Nechushtan A, Xi XG, Youle RJ. Movement of Bax from the cytosol to mitochondria during apoptosis. J Cell Biol. 1997;139(5):1281\u201392.","journal-title":"J Cell Biol"},{"issue":"6","key":"44_CR54","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.molcel.2004.05.018","volume":"14","author":"T Bartke","year":"2004","unstructured":"Bartke T, Pohl C, Pyrowolakis G, Jentsch S. Dual role of BRUCE as an antiapoptotic IAP and a chimeric E2\/E3 ubiquitin ligase. Mol Cell. 2004;14(6):801\u201311.","journal-title":"Mol Cell"},{"issue":"20","key":"44_CR55","doi-asserted-by":"crossref","first-page":"14553","DOI":"10.1016\/S0021-9258(18)82362-6","volume":"268","author":"RJ Davis","year":"1993","unstructured":"Davis RJ. The mitogen-activated protein kinase signal transduction pathway. J Biol Chem. 1993;268(20):14553\u20136.","journal-title":"J Biol Chem"},{"issue":"3","key":"44_CR56","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1128\/MCB.16.3.1212","volume":"16","author":"TL Fisher","year":"1996","unstructured":"Fisher TL, Blenis J. Evidence for two catalytically active kinase domains in pp90rsk. Mol Cell Biol. 1996;16(3):1212\u20139.","journal-title":"Mol Cell Biol"},{"issue":"3","key":"44_CR57","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1074\/jbc.273.3.1496","volume":"273","author":"KN Dalby","year":"1998","unstructured":"Dalby KN, Morrice N, Caudwell FB, Avruch J, Cohen P. Identification of regulatory phosphorylation sites in mitogen-activated protein kinase (MAPK)-activated protein kinase-1a\/p90rsk that are inducible by MAPK. J Biol Chem. 1998;273(3):1496\u2013505.","journal-title":"J Biol Chem"},{"issue":"15","key":"44_CR58","doi-asserted-by":"publisher","first-page":"5787","DOI":"10.1073\/pnas.0600103103","volume":"103","author":"S Abu-Hamad","year":"2006","unstructured":"Abu-Hamad S, Sivan S, Shoshan-Barmatz V. The expression level of the voltage-dependent anion channel controls life and death of the cell. Proc Natl Acad Sci U S A. 2006;103(15):5787\u201392.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"44_CR59","first-page":"2893","volume":"29","author":"A Antonsson","year":"2009","unstructured":"Antonsson A, Persson JL. Induction of apoptosis by staurosporine involves the inhibition of expression of the major cell cycle proteins at the G (2)\/m checkpoint accompanied by alterations in Erk and Akt kinase activities. Anticancer Res. 2009;29(8):2893\u20138.","journal-title":"Anticancer Res"},{"issue":"3","key":"44_CR60","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0960-9822(00)00310-9","volume":"10","author":"A Shimamura","year":"2000","unstructured":"Shimamura A, Ballif BA, Richards SA, Blenis J. Rsk1 mediates a MEK-MAP kinase cell survival signal. Curr Biol. 2000;10(3):127\u201335.","journal-title":"Curr Biol"},{"issue":"4","key":"44_CR61","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/S0092-8674(00)81382-3","volume":"87","author":"J Zha","year":"1996","unstructured":"Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X (L). Cell. 1996;87(4):619\u201328.","journal-title":"Cell"},{"issue":"4","key":"44_CR62","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1046\/j.1471-4159.2001.00096.x","volume":"76","author":"HS Chun","year":"2001","unstructured":"Chun HS, Gibson GE, DeGiorgio LA, Zhang H, Kidd VJ, Son JH. Dopaminergic cell death induced by MPP (+), oxidant and specific neurotoxicants shares the common molecular mechanism. J Neurochem. 2001;76(4):1010\u201321.","journal-title":"J Neurochem"},{"issue":"10","key":"44_CR63","doi-asserted-by":"crossref","first-page":"3552","DOI":"10.1523\/JNEUROSCI.20-10-03552.2000","volume":"20","author":"G Tezel","year":"2000","unstructured":"Tezel G, Wax MB. The mechanisms of hsp27 antibody-mediated apoptosis in retinal neuronal cells. J Neurosci. 2000;20(10):3552\u201362.","journal-title":"J Neurosci"},{"issue":"1","key":"44_CR64","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1172\/JCI119517","volume":"100","author":"K Yanase","year":"1997","unstructured":"Yanase K, Smith RM, Puccetti A, Jarett L, Madaio MP. Receptor-mediated cellular entry of nuclear localizing anti-DNA antibodies via myosin 1. J Clin Invest. 1997;100(1):25\u201331.","journal-title":"J Clin Invest"},{"issue":"2","key":"44_CR65","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1212\/WNL.0b013e31827b90d1","volume":"80","author":"D Besong-Agbo","year":"2013","unstructured":"Besong-Agbo D, Wolf E, Jessen F, Oechsner M, Hametner E, Poewe W, et al. Naturally occurring alpha-synuclein autoantibody levels are lower in patients with Parkinson disease. Neurology. 2013;80(2):169\u201375.","journal-title":"Neurology"},{"key":"44_CR66","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/1742-2094-7-90","volume":"7","author":"J Magga","year":"2010","unstructured":"Magga J, Puli L, Pihlaja R, Kanninen K, Neulamaa S, Malm T, et al. Human intravenous immunoglobulin provides protection against Abeta toxicity by multiple mechanisms in a mouse model of Alzheimer\u2019s disease. J Neuroinflammation. 2010;7:90.","journal-title":"J Neuroinflammation"},{"issue":"3","key":"44_CR67","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S1474-4422(13)70014-0","volume":"12","author":"R Dodel","year":"2013","unstructured":"Dodel R, Rominger A, Bartenstein P, Barkhof F, Blennow K, Forster S, et al. Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer\u2019s disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial. Lancet Neurol. 2013;12(3):233\u201343.","journal-title":"Lancet Neurol"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12886-015-0044-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-015-0044-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-015-0044-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-015-0044-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T15:39:15Z","timestamp":1630597155000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-015-0044-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,27]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["44"],"URL":"https:\/\/doi.org\/10.1186\/s12886-015-0044-9","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,27]]},"assertion":[{"value":"8 September 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"64"}}